These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 25544730)
1. Human adipose-derived stem cells attenuate inflammatory bowel disease in IL-10 knockout mice. Jung WY; Kang JH; Kim KG; Kim HS; Jang BI; Park YH; Song IH Tissue Cell; 2015 Feb; 47(1):86-93. PubMed ID: 25544730 [TBL] [Abstract][Full Text] [Related]
2. Characterisation of enterocolitis in the piroxicam-accelerated interleukin-10 knock out mouse--a model mimicking inflammatory bowel disease. Holgersen K; Kvist PH; Markholst H; Hansen AK; Holm TL J Crohns Colitis; 2014 Feb; 8(2):147-60. PubMed ID: 23994255 [TBL] [Abstract][Full Text] [Related]
4. Flaxseed oil and inflammation-associated bone abnormalities in interleukin-10 knockout mice. Cohen SL; Moore AM; Ward WE J Nutr Biochem; 2005 Jun; 16(6):368-74. PubMed ID: 15936649 [TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Stem Cells Decrease Oxidative Stress in the Bowels of Interleukin-10 Knockout Mice. Jung KJ; Lee GW; Park CH; Lee TJ; Kim JY; Sung EG; Kim SY; Jang BI; Song IH Gut Liver; 2020 Jan; 14(1):100-107. PubMed ID: 31158947 [No Abstract] [Full Text] [Related]
6. Dietary β-glucan regulates the levels of inflammatory factors, inflammatory cytokines, and immunoglobulins in interleukin-10 knockout mice. Ye MB; Bak JP; An CS; Jin HL; Kim JM; Kweon HJ; Choi DK; Park PJ; Kim YJ; Lim BO J Med Food; 2011 May; 14(5):468-74. PubMed ID: 21434779 [TBL] [Abstract][Full Text] [Related]
7. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2. Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922 [TBL] [Abstract][Full Text] [Related]
8. Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Zhu Y; Mahon BD; Froicu M; Cantorna MT Eur J Immunol; 2005 Jan; 35(1):217-24. PubMed ID: 15593122 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of a novel IL-10 deficient cell transfer model for colitis. Ikenoue Y; Tagami T; Murata M Int Immunopharmacol; 2005 Jun; 5(6):993-1006. PubMed ID: 15829415 [TBL] [Abstract][Full Text] [Related]
10. 5-Lipoxygenase-derived lipid mediators are not required for the development of NSAID-induced inflammatory bowel disease in IL-10-/- mice. Narushima S; DiMeo D; Tian J; Zhang J; Liu D; Berg DJ Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G477-88. PubMed ID: 18048478 [TBL] [Abstract][Full Text] [Related]
11. Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease. Hale LP; Greer PK; Trinh CT; Gottfried MR Clin Immunol; 2005 Aug; 116(2):135-42. PubMed ID: 15936249 [TBL] [Abstract][Full Text] [Related]
12. Potential therapeutic utility of mesenchymal stem cells in inflammatory bowel disease in mice. Abdel Salam AG; Ata HM; Salman TM; Rashed LA; Sabry D; Schaalan MF Int Immunopharmacol; 2014 Oct; 22(2):515-21. PubMed ID: 25133649 [TBL] [Abstract][Full Text] [Related]
13. Comparison of experimental mouse models of inflammatory bowel disease. Oh SY; Cho KA; Kang JL; Kim KH; Woo SY Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic application of mesenchymal stromal cells in murine models of inflammatory bowel disease. Gonzalez-Rey E; Delgado M Methods Mol Biol; 2014; 1213():331-9. PubMed ID: 25173395 [TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice. Bamba S; Lee CY; Brittan M; Preston SL; Direkze NC; Poulsom R; Alison MR; Wright NA; Otto WR J Pathol; 2006 Jun; 209(2):265-73. PubMed ID: 16550633 [TBL] [Abstract][Full Text] [Related]